Pages that link to "Q43244686"

The following pages link to Matthew Links (Q43244686):

Displaying 36 items.

• Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer (Q24811840) (← links)
• A phase 1 and pharmacokinetic study of gemcitabine and oxaliplatin in patients with solid tumors (Q33369439) (← links)
• Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. (Q33588520) (← links)
• Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate (Q36535928) (← links)
• Analogies between reading of medical and religious texts. (Q36655809) (← links)
• Reflections. The Drover's Wife. (Q38425090) (← links)
• Implementing a multi-professional web-based learning environment for a comprehensive cancer centre: obstacles, solutions and reflections. (Q38568443) (← links)
• Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy--a journey to becoming a Nationally Funded Peritonectomy Center. (Q38573610) (← links)
• Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model. (Q39644566) (← links)
• Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer (Q43244627) (← links)
• What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? (Q46626941) (← links)
• Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation (Q46843408) (← links)
• Phase I and pharmacokinetic study of weekly NV06 (Phenoxodiol), a novel isoflav-3-ene, in patients with advanced cancer (Q46931643) (← links)
• Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysis (Q47262054) (← links)
• A preliminary study to develop an intervention to facilitate communication between couples in advanced cancer (Q48050527) (← links)
• Advance care planning: a step in the right direction (Q48096803) (← links)
• Beyond competency-based continuing professional development (Q48140230) (← links)
• Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer-A Meta-Analysis. (Q51372253) (← links)
• Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target. (Q51532100) (← links)
• Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial (Q51816015) (← links)
• Discourses of professionalism: Metaphors, theory and practice. (Q52633084) (← links)
• Impact of Specific Epidermal Growth Factor Receptor (EGFR) Mutations and Clinical Characteristics on Outcomes After Treatment With EGFR Tyrosine Kinase Inhibitors Versus Chemotherapy in EGFR-Mutant Lung Cancer: A Meta-Analysis. (Q54276508) (← links)
• Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma (Q62075797) (← links)
• A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer (Q71816291) (← links)
• Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms (Q79896067) (← links)
• Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study (Q79958014) (← links)
• Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy (Q80048741) (← links)
• Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma: non-mucinous tumour associated with an improved survival (Q80055967) (← links)
• Randomized phase 2 sequencing and pharmacokinetic study of gemcitabine and oxaliplatin in advanced non-small cell lung cancer (Q82860051) (← links)
• The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C (Q83438797) (← links)
• Second opinions: agendas and ego (Q84797848) (← links)
• A proposal for a simplified MASCC score (Q85714115) (← links)
• Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation (Q87533545) (← links)
• Finding common ground: meta-synthesis of communication frameworks found in patient communication, supervision and simulation literature (Q89661924) (← links)
• Does supporting the profession really conflict with supporting the community? (Q91800916) (← links)
• Revalidation--what is the problem and what are the possible solutions? (Q95372435) (← links)